CLINICAL_TRIALS
research
· 2019-01-29
Clinical Trial Update: Chemokine (CXCL13) as Anew Marker in Diagnosis of SLE
Summary
This clinical trial update discusses evaluating the chemokine CXCL13 as a new diagnostic biomarker for systemic lupus erythematosus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Assiut University | Conditions: Systemic Lupus | Status: UNKNOWN